Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.
Phase of Trial: Phase IV
Latest Information Update: 29 Sep 2009
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Urinary tract infections
- Focus Therapeutic Use
- Sponsors Wyeth
- 29 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2005 New trial record.